# Single-Center Prospective Study to Investigate the Difference in the Incidence of Contrast-Induced Nephropathy in High-Risk Patients With the Use of the Dye-Vert Plus System

> **NCT04279457** · PHASE4 · RECRUITING · sponsor: **CAMC Health System** · enrollment: 1802 (estimated)

## Conditions studied

- AKI (Acute Kidney Injury) Due to Trauma

## Interventions

- **DEVICE:** DyeVert Plus System
- **OTHER:** Standardized hydration protocol

## Key facts

- **NCT ID:** NCT04279457
- **Lead sponsor:** CAMC Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-02-03
- **Primary completion:** 2022-01-01
- **Final completion:** 2022-02-03
- **Target enrollment:** 1802 (ESTIMATED)
- **Last updated:** 2020-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04279457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04279457, "Single-Center Prospective Study to Investigate the Difference in the Incidence of Contrast-Induced Nephropathy in High-Risk Patients With the Use of the Dye-Vert Plus System". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04279457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*